Sponsor content
322 result(s) found, displaying 91 to 100
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
Australian public assessment report (AusPar)AusPAR for Evusheld (tixagevimab and cilgavimab) for treatment of adults with COVID-19.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Prescription medicine decision summaryEvusheld (tixagevimab and cilgavimab) is approved to treat COVID-19